MAP2K1 and neoplasm: Moreover, when the slow‐growing MEK1‐hi tumours were treated with MEK1 inhibitor PD98059 (Di Paola et al., 2010), tumour growth was increased by 130% in WT (p = 0.114 Figure 2d) but not RAG‐/‐ animals (Figure 2e).